Antitumor effect induced by the expression of granulocyte macrophage-colony stimulating factor gene in murine colon carcinoma cells

被引:14
作者
Gunji, Y
Tagawa, M
Matsubara, H
Takenaga, K
Shimada, H
Kondo, F
Suzuki, T
Nakajima, K
Sugaya, M
Asano, T
Ochiai, T
Isono, K
Horitsu, K
Kageyama, H
Nakamura, Y
Sakiyama, S
机构
[1] CHIBA UNIV,SCH MED,DEPT BIOCHEM,CHUO KU,CHIBA 260,JAPAN
[2] CHIBA UNIV,SCH MED,DEPT SURG 2,CHUO KU,CHIBA 260,JAPAN
[3] CHIBA UNIV,SCH MED,DEPT PATHOL,CHUO KU,CHIBA 260,JAPAN
[4] CHIBA CANC RES INST,DIV CHEMOTHERAPY,CHUO KU,CHIBA 260,JAPAN
[5] TOKYO KASEI UNIV,FAC HOME ECON,ITABASHI KU,TOKYO 173,JAPAN
关键词
cytokine; gene therapy; colon tumor;
D O I
10.1016/0304-3835(96)04141-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Murine colon carcinoma cells which secrete several kinds of cytokine after retroviral transduction with corresponding genes, were examined for their antitumor effects in syngeneic mice. The mice inoculated with granulocyte macrophage-colony stimulating factor (GM-CSF) producer cells showed not only prolonged survival but also reduced tumorigenicity. The antitumor effect caused by the expression of interleukin-4 was less than that of GM-CSF, and interleukin-6 producer cells did not show any effects on the survival of the host animals. Histological examination of the GM-CSF-producing tumor revealed predominant infiltration of neutrophils and necrotic change of the tumor. The present study indicates the feasibility of cancer gene therapy with the expression of GM-CSF gene in tumor cells.
引用
收藏
页码:257 / 261
页数:5
相关论文
共 27 条
[1]  
BRATTAIN MG, 1980, CANCER RES, V40, P2142
[2]   IN-VIVO GENE-THERAPY OF HUMAN LUNG-CANCER USING WILD-TYPE P53 DELIVERED BY RETROVIRUS [J].
CARBONE, DP ;
MINNA, JD .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (19) :1437-1438
[3]   TRANSDUCTION OF THE IL2 GENE INTO HUMAN ACUTE-LEUKEMIA CELLS - INDUCTION OF TUMOR REJECTION WITHOUT MODIFYING CELL-PROLIFERATION AND IL2 RECEPTOR EXPRESSION [J].
CIGNETTI, A ;
GUARINI, A ;
CARBONE, A ;
FORNI, M ;
CRONIN, K ;
FORNI, G ;
GANSBACHER, B ;
FOA, R .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (10) :785-791
[4]  
CORBETT TH, 1975, CANCER RES, V35, P2434
[5]   VACCINATION WITH IRRADIATED TUMOR-CELLS ENGINEERED TO SECRETE MURINE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR STIMULATES POTENT, SPECIFIC, AND LONG-LASTING ANTITUMOR IMMUNITY [J].
DRANOFF, G ;
JAFFEE, E ;
LAZENBY, A ;
GOLUMBEK, P ;
LEVITSKY, H ;
BROSE, K ;
JACKSON, V ;
HAMADA, H ;
PARDOLL, D ;
MULLIGAN, RC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (08) :3539-3543
[6]   INTERLEUKIN-2 PRODUCTION BY TUMOR-CELLS BYPASSES T-HELPER FUNCTION IN THE GENERATION OF AN ANTITUMOR RESPONSE [J].
FEARON, ER ;
PARDOLL, DM ;
ITAYA, T ;
GOLUMBEK, P ;
LEVITSKY, HI ;
SIMONS, JW ;
KARASUYAMA, H ;
VOGELSTEIN, B ;
FROST, P .
CELL, 1990, 60 (03) :397-403
[7]  
GASTL G, 1992, CANCER RES, V52, P6229
[8]   TREATMENT OF ESTABLISHED RENAL-CANCER BY TUMOR-CELLS ENGINEERED TO SECRETE INTERLEUKIN-4 [J].
GOLUMBEK, PT ;
LAZENBY, AJ ;
LEVITSKY, HI ;
JAFFEE, LM ;
KARASUYAMA, H ;
BAKER, M ;
PARDOLL, DM .
SCIENCE, 1991, 254 (5032) :713-716
[9]   ISOLATION AND CHARACTERIZATION OF A MOUSE INTERLEUKIN CDNA CLONE THAT EXPRESSES B-CELL STIMULATORY FACTOR-I ACTIVITIES AND T-CELL-STIMULATING AND MAST-CELL-STIMULATING ACTIVITIES [J].
LEE, F ;
YOKOTA, T ;
OTSUKA, T ;
MEYERSON, P ;
VILLARET, D ;
COFFMAN, R ;
MOSMANN, T ;
RENNICK, D ;
ROEHM, N ;
SMITH, C ;
ZLOTNIK, A ;
ARAI, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (07) :2061-2065
[10]  
MILLER AD, 1989, BIOTECHNIQUES, V7, P980